LifeMD Net Invested Capital vs Accounts Payable Analysis

LFMD Stock  USD 6.36  0.02  0.32%   
LifeMD financial indicator trend analysis is infinitely more than just investigating LifeMD Inc recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether LifeMD Inc is a good investment. Please check the relationship between LifeMD Net Invested Capital and its Accounts Payable accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in LifeMD Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

Net Invested Capital vs Accounts Payable

Net Invested Capital vs Accounts Payable Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of LifeMD Inc Net Invested Capital account and Accounts Payable. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between LifeMD's Net Invested Capital and Accounts Payable is 0.54. Overlapping area represents the amount of variation of Net Invested Capital that can explain the historical movement of Accounts Payable in the same time period over historical financial statements of LifeMD Inc, assuming nothing else is changed. The correlation between historical values of LifeMD's Net Invested Capital and Accounts Payable is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Invested Capital of LifeMD Inc are associated (or correlated) with its Accounts Payable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accounts Payable has no effect on the direction of Net Invested Capital i.e., LifeMD's Net Invested Capital and Accounts Payable go up and down completely randomly.

Correlation Coefficient

0.54
Relationship DirectionPositive 
Relationship StrengthWeak

Net Invested Capital

The total amount of capital invested in a company, including both equity and debt, minus any cash or cash equivalents.

Accounts Payable

An accounting item on the balance sheet that represents LifeMD obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of LifeMD Inc are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.
Most indicators from LifeMD's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into LifeMD Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in LifeMD Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
At present, LifeMD's Discontinued Operations is projected to increase significantly based on the last few years of reporting. The current year's Tax Provision is expected to grow to about 449.4 K, whereas Sales General And Administrative To Revenue is forecasted to decline to 0.32.
 2021 2022 2023 2024 (projected)
Interest Expense3.0M1.3M2.6M2.7M
Depreciation And Amortization868.8K3.8M6.6M6.9M

LifeMD fundamental ratios Correlations

0.860.960.940.480.76-0.76-0.940.880.960.880.960.890.030.950.840.810.970.950.760.990.490.07-0.220.850.89
0.860.80.840.070.4-0.37-0.820.720.740.890.740.970.130.831.00.720.840.930.40.80.330.180.030.80.95
0.960.80.970.40.84-0.7-0.960.880.880.920.880.860.120.980.760.90.970.950.840.920.680.16-0.430.80.88
0.940.840.970.240.79-0.59-1.00.950.810.960.810.920.00.990.790.941.00.980.790.880.720.04-0.450.870.94
0.480.070.40.240.54-0.92-0.250.290.70.040.70.04-0.080.30.080.070.320.20.540.61-0.07-0.070.020.250.03
0.760.40.840.790.54-0.74-0.810.740.720.680.720.53-0.170.810.340.750.810.681.00.740.77-0.15-0.710.530.58
-0.76-0.37-0.7-0.59-0.92-0.740.6-0.63-0.9-0.39-0.9-0.390.1-0.62-0.37-0.41-0.65-0.54-0.74-0.85-0.210.080.13-0.57-0.38
-0.94-0.82-0.96-1.0-0.25-0.810.6-0.94-0.81-0.96-0.81-0.920.02-0.99-0.77-0.94-1.0-0.97-0.81-0.88-0.74-0.020.47-0.86-0.93
0.880.720.880.950.290.74-0.63-0.940.790.830.790.82-0.050.920.670.890.930.90.740.840.69-0.02-0.410.950.82
0.960.740.880.810.70.72-0.9-0.810.790.71.00.73-0.010.840.730.630.860.830.720.990.30.03-0.080.790.72
0.880.890.920.960.040.68-0.39-0.960.830.70.70.960.070.950.850.930.950.970.680.780.710.11-0.420.770.98
0.960.740.880.810.70.72-0.9-0.810.791.00.70.73-0.010.840.730.630.860.830.720.990.30.03-0.080.790.72
0.890.970.860.920.040.53-0.39-0.920.820.730.960.730.080.910.940.840.920.980.530.810.520.12-0.190.840.99
0.030.130.120.0-0.08-0.170.10.02-0.05-0.010.07-0.010.080.050.150.18-0.010.05-0.170.02-0.011.00.1-0.010.06
0.950.830.980.990.30.81-0.62-0.990.920.840.950.840.910.050.780.940.990.970.810.90.720.09-0.450.840.93
0.841.00.760.790.080.34-0.37-0.770.670.730.850.730.940.150.780.660.790.90.340.790.240.20.120.770.92
0.810.720.90.940.070.75-0.41-0.940.890.630.930.630.840.180.940.660.920.890.750.720.850.2-0.610.780.87
0.970.840.971.00.320.81-0.65-1.00.930.860.950.860.92-0.010.990.790.920.980.810.920.680.02-0.420.870.93
0.950.930.950.980.20.68-0.54-0.970.90.830.970.830.980.050.970.90.890.980.680.890.60.09-0.280.880.98
0.760.40.840.790.541.0-0.74-0.810.740.720.680.720.53-0.170.810.340.750.810.680.740.77-0.15-0.710.530.58
0.990.80.920.880.610.74-0.85-0.880.840.990.780.990.810.020.90.790.720.920.890.740.390.06-0.140.840.8
0.490.330.680.72-0.070.77-0.21-0.740.690.30.710.30.52-0.010.720.240.850.680.60.770.390.0-0.90.460.58
0.070.180.160.04-0.07-0.150.08-0.02-0.020.030.110.030.121.00.090.20.20.020.09-0.150.060.00.10.020.11
-0.220.03-0.43-0.450.02-0.710.130.47-0.41-0.08-0.42-0.08-0.190.1-0.450.12-0.61-0.42-0.28-0.71-0.14-0.90.1-0.12-0.26
0.850.80.80.870.250.53-0.57-0.860.950.790.770.790.84-0.010.840.770.780.870.880.530.840.460.02-0.120.82
0.890.950.880.940.030.58-0.38-0.930.820.720.980.720.990.060.930.920.870.930.980.580.80.580.11-0.260.82
Click cells to compare fundamentals

LifeMD Account Relationship Matchups

LifeMD fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets3.4M13.1M49.9M25.7M58.5M61.4M
Short Long Term Debt Total844.7K1.1M1.8M4.1M18.9M19.9M
Other Current Liab3.1M1.6M10.0M8.9M10.8M11.4M
Total Current Liabilities4.0M13.5M22.8M31.4M34.8M36.5M
Total Stockholder Equity(988.2K)1.4M26.9M(6.8M)3.5M2.1M
Net Debt(261.9K)(8.1M)(39.5M)168.5K(14.2M)(13.5M)
Retained Earnings(16.6M)(80.2M)(141.9M)(190.6M)(214.3M)(203.6M)
Accounts Payable3.1M10.4M9.1M10.1M11.1M11.6M
Cash1.1M9.2M41.3M4.0M33.1M34.8M
Non Current Assets Total699.1K990.3K5.0M14.4M15.9M16.7M
Cash And Short Term Investments1.1M9.2M41.3M4.0M33.1M34.8M
Net Receivables97.4K997.8K980.1K2.8M5.3M5.5M
Common Stock Total Equity534.0K234.3K307.0K315.5K362.9K377.1K
Common Stock Shares Outstanding9.9M14.3M27.0M31.0M33.9M35.6M
Liabilities And Stockholders Equity3.4M13.1M49.9M25.7M58.5M61.4M
Non Current Liabilities Total600.0K385.3K1.3M1.6M18.1M19.0M
Inventory950.1K1.3M1.6M3.7M2.8M2.9M
Other Stockholder Equity15.1M77.6M164.4M178.9M217.4M228.3M
Total Liab4.6M13.9M24.1M33.0M52.9M55.6M
Total Current Assets2.7M12.1M44.9M11.3M42.6M44.7M
Short Term Debt814.7K872.1K1.3M4.3M1.5M903.8K
Common Stock534.0K234.3K307.0K315.5K383.6K380.6K
Other Current Assets443.0K1.8M996.7K814.3K1.9M2.0M
Current Deferred Revenue109.6K916.9K1.5M5.5M8.8M9.3M
Net Tangible Assets(1.7M)(3.0M)19.7M(19.5M)(17.6M)(16.7M)
Net Invested Capital(173.5K)(1.5M)22.8M(8.6M)21.8M22.8M
Short Long Term Debt814.7K779.1K63.4K2.8M327.6K311.2K
Net Working Capital(1.2M)(1.4M)22.1M(20.1M)7.8M8.2M
Capital Stock534.0K3.9M4.4M4.9M383.7K364.5K
Intangible Assets675.5K715.8K3.0M12.7M14.8M15.5M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether LifeMD Inc is a strong investment it is important to analyze LifeMD's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact LifeMD's future performance. For an informed investment choice regarding LifeMD Stock, refer to the following important reports:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in LifeMD Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of LifeMD. If investors know LifeMD will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about LifeMD listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.64)
Revenue Per Share
4.847
Quarterly Revenue Growth
0.383
Return On Assets
(0.21)
Return On Equity
(7.82)
The market value of LifeMD Inc is measured differently than its book value, which is the value of LifeMD that is recorded on the company's balance sheet. Investors also form their own opinion of LifeMD's value that differs from its market value or its book value, called intrinsic value, which is LifeMD's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because LifeMD's market value can be influenced by many factors that don't directly affect LifeMD's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between LifeMD's value and its price as these two are different measures arrived at by different means. Investors typically determine if LifeMD is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, LifeMD's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.